AUG 01, 2017 7:06 PM PDT

Uncovering HIV Hiding Spots in the Body

WRITTEN BY: Kara Marker

Scientists have known for a while that HIV hides in the body, undetected by the immune system and unaffected by antiretroviral drugs, but where specifically? Researchers from the University of Michigan have narrowed it down to specific cells in the bone marrow, highlighting a new opportunity for an anti-HIV drug that could finally get rid of the virus completely.

 

Credit: University of Michigan

 

HIV is hard to get rid of entirely. Despite the latest anti-retroviral drug technologies, HIV hides in the body, waiting to “pounce” once the drugs stop to cause an infection, which can lead to AIDS. The way HIV “lurks” is similar to the way the varicella virus, which causes chickenpox, hides out in long-living nerve cells and causes shingles later in life. Current drugs keep HIV at bay, preventing AIDS, but they don’t completely rid the body of the virus.

"Looking for the cells that harbor functional HIV is like searching for a needle in a haystack,” explained research leader Kathleen Collins, MD, PhD. “Our new results expand our understanding of the type of cells that can do it.”

Thanks to several long-term HIV patients who donated bone marrow samples, Collins and her team were able to observe HIV hiding in bone marrow cells, and they saw that HIV was present in many different cell types. Cells harboring the virus divide, passing HIV genetic material to future generations of cells.

They found that HIV hides in hematopoietic progenitor cells (HPCs), which replace blood cells as they get older and die, “blood cells in waiting.” Here, HIV hijacks the HPC’s cellular machinery so the cell starts cranking out viral proteins. To do so, HIV attaches to a CD4 receptor on the surface of HPCs. Two HIV subtypes are capable of binding CD4, those utilizing CXCR4 and CCR5 receptors.

HPCs can live for years, making them a smart choice for HIV to set up shop. However, identifying HPCs as HIV hideouts shows researchers exactly what cell type to target. Collins’s team is doing just that - researching new treatment options that can target HPCs specifically, leaving other bone marrow cells unharmed to minimize collateral damage.

"Today's medications have side effects, as well as financial costs,” Collins pointed out. “To get to the next step, we need to target the types of cells that form a latent infection, including these progenitor cells."

According to the Centers for Disease Control and Prevention, over one million people in the United States are living with HIV, and 1 in 7 of them are completely unaware.

The present study was published in the journal PLOS Pathogens.

Source: Michigan Medicine/University of Michigan, CDC

 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 26, 2021
Cancer
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
JUN 26, 2021
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
Research shows that obese patients with cancers including ovarian and melanoma may respond better to a certain kind of i ...
JUL 06, 2021
Immunology
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
JUL 06, 2021
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
Inflammatory conditions are linked to an overactive immune system, and resolving them therapeutically often involves cal ...
JUL 27, 2021
Immunology
Rethinking Immune Responses Involved in Skin Hypersensitivity
JUL 27, 2021
Rethinking Immune Responses Involved in Skin Hypersensitivity
A study by immunologists at the University of Copenhagen has revealed a never-before-seen immune pathway invol ...
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 18, 2021
Cannabis Sciences
Cannabis Use Disorder Linked to COVID Hospitalization
AUG 18, 2021
Cannabis Use Disorder Linked to COVID Hospitalization
People with a genetic predisposition to cannabis use disorder (CUD) are more likely to require hospitalization after con ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
Loading Comments...